ISPOR Institutional Council

ISPOR Institutional Council Mission

The ISPOR Institutional Council supports the mission of ISPOR as a scientific and professional society. The purpose of the council is to proactively:

Promote the development of the fields of pharmacoeconomics and outcomes research
Promote the application of pharmacoeconomics and outcomes research results in health care decision making
Promote enhancement of the quality of research by institutional members
Promote, support, and actively contribute to ISPOR as a premier scientific and professional society.
Act as an advisory body to the ISPOR board.

The Institutional Council is an official entity within ISPOR and will not publicly take positions outside of ISPOR or use ISPOR’s name, except with the explicit consent of the ISPOR Board.

ISPOR Institutional Council Initiatives

ISPOR Institutional Council initiatives over the past several years are:

During 2006-2007, the Council initiated development of a Value in Health Special Issue, "Health Technology Assessment In “Evidence Based Medicine: Formulary And Health Care Reimbursement Decisions In The United States."
During 2005, Journal of the American Medical Association (JAMA) introduced new Instructions for Authors: Manuscript Submission (Vol. 293 No. 14, April 13, 2005 http://jama.ama-assn.org/ifora_current.dtl ) on data access and responsibility. “For reports containing original data, at least 1 author (e.g., the principal investigator) who is independent of any commercial funder should indicate that she or he "had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis." For industry-sponsored studies, the data analysis should be conducted by statisticians at an academic center, rather than only by statisticians employed by the company sponsoring the research. In 2005, the Council drafted a letter for the Board of Directors to send to JAMA Editor-in-Chief concerning this policy. In 2006, a modified letter was sent by the Board to the JAMA Editor-in-Chief. ISPOR Letter to JAMA, JAMA Policy, and JAMA Response to ISPOR is at: http://www.ispor.org/workpaper/ispor_comments/index.asp
During 2004, the Council recommended that ISPOR develop a plan to assist health care decision-makers in developing an analytical framework to deal with “real world” data and information in health care decision-making and health care coverage and reimbursement decisions. Toward this goal, the ISPOR Using 'Real World' Data In Coverage and Reimbursement Decisions Task Force was formed. The report of the Task Force will be published in Value in Health, Vol. 10, Issue 5 (Sept-October) 2007.
During 2003, the Council-initiated Value in Health Special Issue, “Moving Beyond the Drug Budget Silo Mentality in Europe” which was published as a supplement to Value in Health in Vol. 6 (July/August) 2003.
During 2002, the Council initiated 3 projects to address ISPOR student issues. The Council conducted an Intern Employer Survey; co-developed (with the ISPOR Student Council) the Intern Professional Recruitment Program (IPRAP) at: http://www.ispor.org/iprap/index.asp; and developed a list of dissertation projects
During 2001, the Council initiated and funded a symposium within the Academy of Managed Care Pharmacy’s Education Conference, October, 2001, titled: “Bridging The Gap: Utilizing Health Economics, Outcomes Research & Partnerships to Enhance Formulary Decision-Making.”

ISPOR Institutional Council Chair

ISPOR Institutional Council Members